Get the latest delivered to your inbox
Privacy Policy

Now Reading

Shorter corn stalks, drones and more: Inside Bayer Crop Science's $2B R&D pipeline

By Nathan Rubbelke - St. Louis Inno editor

Shorter corn stalks, drones and more: Inside Bayer Crop Science's $2B R&D pipeline

By Nathan Rubbelke - St. Louis Inno editor

Published 09-09-22

Submitted by Bayer

" "
A drone sprays soybean crops at Bayer's Agronomy Center in Jerseyville, Illinois. Nathan Rubbelke. Image courtesy of bizjournals.com

Originally Published by St. Louis Inno on bizjournals.com

Two subjects are top of mind for Bayer Crop Science President Rodrigo Santos

“We do believe that more than ever, not only because of the pandemic but also because of the war in Ukraine, there are two things that really become even more important than any other topic: food security and climate change,” Santos said. "Those two topics are probably on the agenda of every conversation that we have.”

" "
Bayer Crop Science's short-stature corn hybrids (left) are grown next to traditional corn hybrids at Bayer's Agronomy Center in Jerseyville, Illinois. Nathan Rubbelke. Image courtesy of bizjournals.com

Bayer Crop Science, which has its North American headquarters in Creve Coeur, has put those two topics at the center of its research and development initiatives, developing new products that it believes will help mitigate food insecurity and climate change.

Continue Reading Here

Bayer logo

Bayer

Bayer

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.

More from Bayer

Join today and get the latest delivered to your inbox